Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo

Drug and Alcohol Dependence

Volumn 87, Issue 1, 2007, Pages 20-29

  Levin, Frances R ^a   Evans, Suzette M ^a   Brooks, Daniel J ^a   Garawi, Fatima ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Cocaine dependence; Methylphenidate; Treatment

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; AFRICAN AMERICAN; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CAUCASIAN; CLENCHED JAW; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HELP SEEKING BEHAVIOR; HISPANIC; HUMAN; INSOMNIA; INTERVIEW; JAW DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MOOD; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; TREATMENT RESPONSE; URINALYSIS;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE-RELATED DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MASS SCREENING; METHYLPHENIDATE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 33846055951     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.07.004     Document Type: Article

References (56)

1. APA, American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
2. Biederman J., Mick E., Surman C., Doyle R., Hammerness P., Harpold T., Dunkel S., Dougherty M., Aleardi M., and Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry (2005)
3. Bouffard R., Hechtman L., Minde K., and Iaboni-Kassab F. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can. J. Psychiatry 48 (2003) 546-554
4. Brady K.T., Sonne S., Anton R.F., Randall C.L., Back S.E., and Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin. Exp. Res. 29 3 (2005) 395-401
5. Carroll K.M., and Rounsaville B.J. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr. Psychiatry 34 (1993) 75-82
6. Carroll K.M., Rounsaville B.J., Gordon L.T., Nich C., Jatlow P., Bisighini R.M., and Gawin F.H. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch. Gen. Psychiatry 51 (1994) 177-187
7. Castaneda R., Levy R., Hardy M., and Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults. Psychiatr. Serv. 51 (2000) 169-171
8. Clure C., Brady K.T., Saladin M.E., Johnson D., Waid R., and Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am. J. Drug Alcohol Abuse 25 (1999) 441-448
9. Collins S.L., Levin F.R., Foltin R.W., Kleber H.D., and Evans S.M. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend. 82 2 (2006) 158-167
10. Crits-Christoph P., Siqueland L., Blaine J., Frank A., Luborsky L., Onken L.S., Muenz L.R., Thase M.E., Weiss R.D., Gastfriend D.R., Woody G.E., Barber J.P., Butler S.F., Daley D., Salloum I., Bishop S., Najavits L.M., Lis J., Mercer D., Griffin M.L., Moras K., and Beck A.T. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch. Gen. Psychiatry 56 (1999) 493-502
11. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., and O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 (2005) 205-211
12. Del Boca F.K., Kranzler H.R., Brown J., and Korner P.F. Assessment of medication complaicne in alcoholics through UV light detection of a riboflavin tracer. Alcoholism: Clin. Exp. Res. 20 8 (1996) 1412-1417
13. Dorrego M.F., Canevaro L., Kuzis G., Sabe L., and Starkstein S.E. A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings. J. Neuropsychiatry Clin. Neurosci. 14 (2002) 289-295
14. Elkashef A., Holmes T.H., Bloch D.A., Shoptaw S., Kampman K., Reid M.S., Somoza E., Ciraulo D., Rotrosen J., Leiderman D., Montgomery A., and Vocci F. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence. Addiction 100 Suppl. 1 (2005) 91-101
15. First M.B., Spitzer R.L., Gibbon M., and William J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Verision 2.0) (1995), Biometrics Research Department, New York State Psychiatric Institute
16. Fitzpatrick P.A., Klorman R., Brumaghim J.T., and Borgstedt A.D. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. J. Am. Acad. Child Adolesc. Psychiatry 31 2 (1992) 226-234
17. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., and Moeller F.G. Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J. Clin. Psychopharmacol. 21 (2001) 522-526
18. Grabowski J., Rhoades H., Stotts A., Cowan K., Kopecky C., Dougherty A., Moeller F.G., Hassan S., and Schmitz J. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29 (2004) 969-981
19. Grabowski J., Roache J.D., Schmitz J.M., Rhoades H., Creson D., and Korszun A. Replacement medication for cocaine dependence: methylphenidate. J. Clin. Psychopharmacol. 17 (1997) 485-488
20. Guy W. ECDEU Assessment Manual for Psychopharmacology (1976), National Institute for Mental Health, Rockville, MD
21. Hien, D., Matzner, F., First, M., Spitzer, R., William, J., 1994. The Structured Clinical Interview for DSM-IV, Childhood version (KID-SCI), Unpublished document.
22. Khantzian E.J. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am. J. Psychiatry 140 (1983) 784-785
23. Khantzian E.J., Gawin F., Kleber H.D., and Riordan C.E. Methylphenidate (Ritalin) treatment of cocaine dependence-a preliminary report. J. Subst. Abuse Treat. 1 (1984) 107-112
24. King V.L., Brooner R.K., Kidorf M.S., Stoller K.B., and Mirsky A.F. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J. Nerv. Ment. Dis. 187 (1999) 487-495
25. Kooij J.J., Burger H., Boonstra A.M., Van der Linden P.D., Kalma L.E., and Buitelaar J.K. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol. Med. 34 (2004) 973-982
26. Levin F.R., Evans S.M., Brooks D.J., Kalbag A.S., Garawi F., and Nunes E.V. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend. 81 (2006) 137-148
27. Levin F.R., Evans S.M., and Kleber H.D. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 52 (1998) 15-25
28. Levin F.R., Evans S.M., McDowell D.M., and Kleber H.D. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J. Clin. Psychiatry 59 (1998) 300-305
29. Levin F.R., Evans S.M., Vosburg S.K., Horton T., Brooks D., and Ng J. Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict. Behav. 29 (2004) 1875-1882
30. Magura S., Goldsmith D., Casriel C., Goldstein P.J., and Lipton D. The validity of methadone clients' self-reported drug use. Int. J. Addict. 22 (1987) 727-749
31. Markowitz J.S., Straughn A.B., and Patrick K.S. Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. Pharmacotherapy 23 (2003) 1281-1299
32. McDowell D., Nunes E.V., Seracini A.M., Rothenberg J., Vosburg S.K., Ma G.J., and Petkova E. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial. Drug Alcohol Depend. 80 (2005) 209-221
33. Murphy K.R., and Barkley R.A. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications of clinical diagnosis. J. Atten. Disord. 1 (1996) 147-161
34. Paterson R., Douglas C., Hallmayer J., Hagan M., and Krupenia Z. A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust. N. Z. J. Psychiatry 33 (1999) 494-502
35. Pelham W.E., Greenslade K.E., Vodde-Hamilton M., Murphy D.A., Greenstein J.J., Gnagy E.M., Guthrie J., Hoover M.D., and Dahl R.E. Relative efficacy of long-acting stimulants on ADHD children: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics 86 (1990) 226-237
36. Pettinati H.M., Volpicelli J.R., Luck G., Kranzler H.R., Rukstalis M.R., and Cnaan A. Double-blind clinical trial of sertraline treatment for alcohol dependence. J. Clin. Pscyhopharmacol. 21 (2001) 143-153
37. Preston K.L., Silverman K., Schuster C.R., and Cone E.J. Use of quantitative urinalysis in monitoring cocaine use. NIDA Res. Monogr. 175 (1997) 253-264
38. Riggs P.D., Hall S.K., Mikulich-Gilbertson S.K., Lohman M., and Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J. Am. Acad. Child Adolesc. Psychiatry 43 (2004) 420-429
39. Safren S.A., Sprich S., Chulvick S., and Otto M.W. Psychosocial treatments for adults with attention-deficit/hyperactivity disorder. Psychiatr. Clin. North Am. 27 (2004) 349-360
40. Schubiner H., Saules K.K., Arfken C.L., Johanson C.E., Schuster C.R., Lockhart N., Edwards A., Donlin J., and Pihlgren E. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp. Clin. Psychopharmacol. 10 (2002) 286-294
41. Schubiner H., Tzelepis A., Milberger S., Lockhart N., Kruger M., Kelley B.J., and Schoener E.P. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J. Clin. Psychiatry 61 (2000) 244-251
42. Shearer J., Wodak A., van Beek I., Mattick R.P., and Lewis J. Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction 98 (2003) 1137-1141
43. Somoza E.C., Winhusen T.M., Bridge T.P., Rotrosen J.P., Vanderburg D.G., Harrer J.M., Mezinskis J.P., Montgomery M.A., Ciraulo D.A., Wulsin L.R., and Barrett J.A. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J. Addict. Dis. 23 (2004) 77-92
44. Spencer T., Biederman J., Wilens T., Doyle R., Surman C., Prince J., Mick E., Aleardi M., Herzig K., and Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 (2005) 456-463
45. Spencer T., Biederman J., Wilens T., Faraone S., Prince J., Gerard K., Doyle R., Parekh A., Kagan J., and Bearman S.K. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 58 (2001) 775-782
46. Spencer T., Biederman J., Wilens T., Prince J., Hatch M., Jones J., Harding M., Faraone S.V., and Seidman L. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 155 (1998) 693-695
47. Spencer T., Wilens T., Biederman J., Faraone S.V., Ablon J.S., and Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry 52 (1995) 434-443
48. Stevenson C.S., Whitmont S., Bornholt L., Livesey D., and Stevenson R.J. A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust. N. Z. J. Psychiatry 36 (2002) 610-616
49. Swanson J.M., and Volkow N.D. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci. Biobehav. Rev. 27 (2003) 615-621
50. Ward M.F., Wender P.H., and Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am. J. Psychiatry 150 (1993) 885-890
51. Weiss, G, Hechtman, L.T., 1986. Adult hyperactive subjects' view of their treatment in childhood and adolescence. In: Hyperactive Children Grown Up: Empirical Finding and Theoretical Considersations. New York, Guilford, p. 293.
52. Wender P.H., Reimherr F.W., Wood D., and Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am. J. Psychiatry 142 (1985) 547-552
53. Whitehouse D., Shah U., and Palmer F.R. Comparison of sustained-release and standard methylphenidate in the treatment of minimal brain dysfunction. J. Clin. Psychiatry 41 (1980) 282-285
54. Wilens T.E., Biederman J., Spencer T.J., Bostic J., Prince J., Monuteaux M.C., Soriano J., Fine C., Abrams A., Rater M., and Polisner D. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 156 (1999) 1931-1937
55. Wilens T.E., Biederman J., Spencer T.J., and Prince J. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J. Clin. Psychopharmacol. 15 (1995) 270-279
56. Wise B.K., Cuffe S.P., and Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J. Subst. Abuse Treat. 21 (2001) 161-165